Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023

This study uses data from US retail pharmacies to assess national GLP-1RA dispensing to adolescents and young adults from 2020-2023.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2024-06, Vol.331 (23), p.2041-2043
Hauptverfasser:	Lee, Joyce M, Sharifi, Mona, Oshman, Lauren, Griauzde, Dina H, Chua, Kao-Ping
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Adult Adults Anti-Obesity Agents - administration & dosage Anti-Obesity Agents - supply & distribution Anti-Obesity Agents - therapeutic use Child Diabetes Mellitus, Type 2 - drug therapy Dispensing Drug Prescriptions - statistics & numerical data Female Glucagon Glucagon-like peptide 1 Glucagon-Like Peptide-1 Receptor - agonists Glucagon-Like Peptide-1 Receptor Agonists - administration & dosage Glucagon-Like Peptide-1 Receptor Agonists - supply & distribution Glucagon-Like Peptide-1 Receptor Agonists - therapeutic use Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - supply & distribution Hypoglycemic Agents - therapeutic use Letter Letters Male Obesity - drug therapy Online First Research Letter United States - epidemiology United States Food and Drug Administration Young Adult Young adults
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study uses data from US retail pharmacies to assess national GLP-1RA dispensing to adolescents and young adults from 2020-2023.
ISSN:	0098-7484 1538-3598 1538-3598
DOI:	10.1001/jama.2024.7112